MedPath

Povidone-iodine

Generic Name
Povidone-iodine
Brand Names
Betadine, Kenalog, Marbeta, Marcaine, P-Care M, P-Care MG, P-care, P-care X, Summer's Eve Medicated
Drug Type
Small Molecule
CAS Number
25655-41-8
Unique Ingredient Identifier
85H0HZU99M
Background

Povidone-iodine is a stable chemical complex of polyvinylpyrrolidone (povidone, PVP) and elemental iodine. It contains from 9.0% to 12.0% available iodine, calculated on a dry basis. This unique complex was discovered in 1955 at the Industrial Toxicology Laboratories in Philadelphia by H. A. Shelanski and M. V. Shelanski. During in vitro testing to demonstrate anti-bacterial activity it was found that the complex was less toxic in mice than tincture of iodine. Human clinical trials showed the product to be superior to other iodine formulations. Povidone-iodine was immediately marketed, and has since become the universally preferred iodine antiseptic.

Indication

For topical application in the treatment and prevention of infection in wounds.

Associated Conditions
Skin Infections
Associated Therapies
Skin disinfection, Antiseptic skin preparation therapy, Irrigation of the ocular surface therapy, Prepping of the periocular region

Povidone-Iodine for Nasal Decolonization

Phase 4
Completed
Conditions
Methicillin-Resistant Staphylococcus Aureus
Surgical Wound Infection
Preoperative Care
Interventions
Drug: 0.9% NaCl Solution
First Posted Date
2022-09-06
Last Posted Date
2024-11-13
Lead Sponsor
Rutgers, The State University of New Jersey
Target Recruit Count
192
Registration Number
NCT05529173
Locations
🇺🇸

University Hospital, Newark, New Jersey, United States

Efficacy of Diluted Betadine vs Antibiotic Installation Before Surgical Wound Closure in Prevention of Post Cardiac Surgery Wound Infection

Phase 4
Conditions
Surgical Wound Infection
Interventions
First Posted Date
2022-03-11
Last Posted Date
2022-03-11
Lead Sponsor
Assiut University
Target Recruit Count
80
Registration Number
NCT05276687

Treatment of Blepharitis With Povidone-Iodine 1%

Not Applicable
Conditions
Anterior Blepharitis
Interventions
Drug: Eyelid cleansing wipes
First Posted Date
2021-12-16
Last Posted Date
2021-12-16
Lead Sponsor
Shaare Zedek Medical Center
Target Recruit Count
100
Registration Number
NCT05160623
Locations
🇮🇱

Ophthalmology clinic, Shaare Zedek Medical Center, Jerusalem, Israel

Skip Prep of Vaginal Delivery to Prevent Puerperal / Perinatal Infection in Vaginal Delivery

Not Applicable
Not yet recruiting
Conditions
Vaginal Delivery
Surgical Site Infection
Interventions
First Posted Date
2021-11-16
Last Posted Date
2021-11-26
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
4140
Registration Number
NCT05122169

Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement

Phase 3
Active, not recruiting
Conditions
Periprosthetic Joint Infection
Draining Wound
Interventions
Drug: Topical Antibiotic
Drug: Saline Lavage Solution
First Posted Date
2021-10-19
Last Posted Date
2024-02-21
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
500
Registration Number
NCT05084378
Locations
🇨🇦

St. Joseph's Healthcare, Hamilton, Ontario, Canada

🇨🇦

Montreal General Hospital, Montreal, Quebec, Canada

🇨🇦

St. Mary's Hospital, Montreal, Quebec, Canada

and more 3 locations

Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine

Phase 4
Recruiting
Conditions
Eye Infections, Bacterial
Interventions
First Posted Date
2021-07-29
Last Posted Date
2024-11-27
Lead Sponsor
University of Miami
Target Recruit Count
230
Registration Number
NCT04981860
Locations
🇺🇸

Bascom Palmer Eye Institute, Palm Beach Gardens, Florida, United States

🇺🇸

Medical Center Ophthalmology Associates, San Antonio, Texas, United States

Effectiveness of Corticosteroid vs Ketorolac Shoulder Injections

Phase 4
Withdrawn
Conditions
Rotator Cuff Tendinitis
Full-thickness Rotator Cuff Tear
Interventions
First Posted Date
2021-05-20
Last Posted Date
2024-11-15
Lead Sponsor
Michael Khazzam
Target Recruit Count
400
Registration Number
NCT04895280
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Hyaluronic Acid in Postoperative Cures in the Phenol/Alcohol Technique

Early Phase 1
Completed
Conditions
Nails, Ingrown
Hyaluronic Acid
Interventions
Drug: Hialucic
First Posted Date
2021-03-23
Last Posted Date
2023-01-19
Lead Sponsor
University of Malaga
Target Recruit Count
70
Registration Number
NCT04812457
Locations
🇪🇸

Eva Lopezosa Reca, Málaga, Spain

Antiseptic Irrigation for Pleural Infection

Phase 1
Completed
Conditions
Pleural Infection
Interventions
First Posted Date
2021-02-18
Last Posted Date
2022-08-31
Lead Sponsor
Alexandria University
Target Recruit Count
36
Registration Number
NCT04761133
Locations
🇪🇬

Alexandria University Faculty of Medicine, Alexandria, Egypt

Optimizing Preoperative Disinfection of Eyes

Phase 4
Terminated
Conditions
Eye Infections
Interventions
First Posted Date
2021-02-09
Last Posted Date
2021-09-14
Lead Sponsor
Norwegian University of Science and Technology
Target Recruit Count
150
Registration Number
NCT04745663
Locations
🇳🇴

St Olavs Hospital, Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath